Endocrinology
Dr. Amit Desai
Recent Articles
19 totalEndocrinology
FDA Submits NDA for CagriSema: Fixed-Dose Combination of Cagrilintide and Semaglutide for Obesity Management
FDA submits NDA for CagriSema: a fixed-dose combination of cagrilintide and semaglutide for obesity management.
Endocrinology
FDA Approves Foundayo: New GLP-1 Pill for Obesity Management
FDA approves Foundayo for obesity management: a new oral GLP-1 receptor agonist enhancing treatment options for clinicians.
Endocrinology
FDA Approves Zepbound for Weight Management: Key Differences from Mounjaro
FDA approves Zepbound for weight management: key differences from Mounjaro for diabetes treatment.
Endocrinology
FDA Submits NDA for CagriSema: Cagrilintide-Semaglutide Combo for Obesity Management
FDA submits NDA for CagriSema: a cagrilintide-semaglutide combo for obesity management, showing significant weight loss.
Endocrinology
FDA Approves Oral Semaglutide for Weight Management: 25 mg Dose for Obesity
FDA approves oral semaglutide (Wegovy) for weight management: 25 mg dose for obesity.
Endocrinology
FDA Approves Tirzepatide for Weight Management: Key Differences Between Mounjaro and Zepbound
Tirzepatide approved for weight management: key differences between Mounjaro and Zepbound.
Endocrinology
Semaglutide Comparison: Ozempic vs Wegovy for Diabetes and Weight Loss
Explore the differences between Ozempic and Wegovy semaglutide doses and indications for diabetes and weight loss management.
Endocrinology
Exploring the Expanding Role of GLP-1 Receptor Agonists Beyond Diabetes Management
Discover the expanding roles of GLP-1 receptor agonists in obesity, cardiovascular health, and neuroprotection beyond diabetes management.
Medical Research
Identify 5 Overeating Types for Targeted Interventions
Wearable sensors track eating habits to inform personalized obesity care and tailored interventions for better patient outcomes.
Healthcare Business
Targeted AFib Screening: Improved Outcomes
Learn how targeted atrial fibrillation screening can improve patient outcomes and reduce unnecessary tests in your practice, despite controversy over mass screening.
Healthcare Business
Boost Rural Healthcare with $10B Annual Funding
Discover how to access $50 billion in federal funding to enhance rural healthcare, improve provider recruitment, and adopt innovative technology.
Healthcare Business
Medicare Pay Cuts: 2.5% Reimbursement Reduction Looms
Proposed 2026 Medicare pay changes may cut reimbursement by 2.5% for thousands of procedures, affecting doctor pay and practice expenses.